Biomarin Pharmaceutical Inc (BMRN)

NASDAQ
Currency in USD
59.27
+1.00(+1.72%)
Closed·
Pre Market
59.270.00(0.00%)
·

BMRN Earnings

Latest Release
May 01, 2025
EPS / Forecast
1.13 / 0.70
Revenue / Forecast
745.00M / 741.02M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
06/2025--/0.838--/761.34M----Free Sign Up
03/20251.13/0.7745M/741.02M+61.43%+0.54%Free Sign Up
12/20240.92/0.55747M/711.42M+67.27%+5%Free Sign Up
09/20240.91/0.53746M/703.14M+71.7%+6.1%Free Sign Up
06/20240.96/0.35712M/662.05M+174.29%+7.54%Free Sign Up
03/20240.71/0.32649M/649.27M+121.87%-0.04%Free Sign Up
12/20230.49/0.2646.2M/639.26M+145%+1.09%Free Sign Up
09/20230.46/0.23581.3M/607.5M+100%-4.31%Free Sign Up
06/20230.54/0.23595.3M/595.22M+134.78%+0.01%Free Sign Up
03/20230.6/0.21596.4M/571.33M+185.71%+4.39%Free Sign Up

All numbers in USD

Biomarin Pharmaceutical Inc Earnings Call Summary for Q1/2025

  • Q1 2025 EPS of $1.13, beating $0.70 forecast; revenue of $745M exceeded $741.02M estimate; stock up 0.8% after hours
  • VOXZOGO global revenue surged 40% YoY; operating cash flow up 271%; company maintains 'GREAT' financial health score of 3.52
  • Full-year VOXZOGO revenue projected at $900M-$950M; $4B revenue target by 2027 with 40%+ operating margin goal
  • CEO: Well-positioned amid market uncertainty; R&D focus on increasing CNP exposure in patients with BMN 333 development
  • Risks include potential pharma tariffs, market saturation, regulatory hurdles, exchange rate fluctuations, and competitive pressures
Last Updated: 2025/05/01, 23:46
Read Full Transcript

FAQ

What Is Biomarin Pharma's Earnings Per Share (TTM)?

The Biomarin Pharma EPS (TTM) is 2.75.

When Is The Next Biomarin Pharma Earnings Date?

Biomarin Pharma will release its next earnings report on 04 Aug 2025.

What Is Biomarin Pharma’s Revenue Forecasts For Upcoming Quarters?

Biomarin Pharma’s revenue forecast is 761.34M.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.